menu
    • menu

    Company profile for Aurigene Oncology

    NEW Drugs in Dev.: 1
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aurigene is a biotechnology company focused on discovering and developing novel therapies for cancer and inflammatory diseases. With a strong commitment to innovation and cutting-edge science, Aurigene specializes in small molecule and biologic therapeutics, aiming to address unmet medical needs. Our mission is to transform patient care by delivering breakthrough treatments that target the underlying causes of serious illnesse...
    Aurigene is a biotechnology company focused on discovering and developing novel therapies for cancer and inflammatory diseases. With a strong commitment to innovation and cutting-edge science, Aurigene specializes in small molecule and biologic therapeutics, aiming to address unmet medical needs. Our mission is to transform patient care by delivering breakthrough treatments that target the underlying causes of serious illnesses. At Aurigene, we are dedicated to advancing healthcare through research excellence, strategic partnerships, and a deep commitment to improving patient outcomes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aurigene Oncologyindia-flag Flag
    Country
    Country
    India
    Address
    Address
    39-40(P), KIADB Industrial Area, Phase II Electronics City Hosur Road Bangalor...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aurigene.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aurigene Oncology Reports Positive Phase 1 Data for AUR112
    Aurigene Oncology Reports Positive Phase 1 Data for AUR112

    02 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251201028387/en/Aurigene-Oncology-Limited-Announces-Encouraging-Initial-Data-From-1st-Two-Cohorts-of-Phase-1-Study-of-AUR112-an-Oral-Small-Molecule-Inhibitor-of-MALT1-in-RelapsedRefractory-Lymphoid-Malignancies

    BUSINESSWIRE
    02 Dec 2025
    Share Share
    Aurigene Oncology Presents A-PROX Platform At AACR-NCI-EORTC
    Aurigene Oncology Presents A-PROX Platform At AACR-NCI-EORTC

    22 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251020997859/en/Aurigene-Oncology-to-Showcase-Innovative-A-PROX-Platform-at-the-AACR-NCI-EORTC-International-Conference-2025

    BUSINESSWIRE
    22 Oct 2025
    Share Share
    Aurigene reports Positive Ph 1 trial for CAR-T cell therapy in India
    Aurigene reports Positive Ph 1 trial for CAR-T cell therapy in India

    09 Oct 2024

    // PRESS RELEASE

    https://www.aurigene.com/aurigene-oncology-limited-announces-promising-results-of-phase-1-study-for-indias-first-trial-for-novel-autologous-car-t-cell-therapy-for-multiple-myeloma/

    PRESS RELEASE
    09 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search